Antitumor effects of anlotinib in thyroid cancer

por Ruan, Xianhui, Shi, Xianle, Dong, Qiman, Yu, Yang, Hou, Xiukun, Song, Xinhao, Wei, Xi, Chen, Lingyi, Gao, Ming
Publicado 2018

PARP inhibitor shuts down the global translation of thyroid cancer through promoting Pol II binding to DIMT1 pause

por Hou, Xiukun, Tian, Mengran, Ning, Junya, Wang, Zhongyu, Guo, Fengli, Zhang, Wei, Hu, Linfei, Wei, Songfeng, Hu, Chuanxiang, Yun, Xinwei, Zhao, Jingzhu, Dong, Qiman, Ruan, Xianhui, Li, Dapeng, Gao, Ming, Zheng, Xiangqian
Publicado 2023